ADAM17 and neoplasm: Thus, only spheroids derived from wild-type tumor cells (A549, H358) were treated in the later experiments with the control antibody IgG1 and the ADAM17-inhibitory antibody MEDI3622 (25 μmol/L, day 11), respectively, and irradiated (5 Gy) 24 hours thereafter.